Jonathan Drachman
2021 - Aquinox Pharmaceuticals
In 2021, Jonathan Drachman earned a total compensation of $2.7M as Chief Executive Officer at Aquinox Pharmaceuticals, a 41% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $208,354 |
|---|---|
| Salary | $438,640 |
| Stock Awards | $1,998,837 |
| Other | $4,300 |
| Total | $2,650,131 |
Drachman received $2M in stock awards, accounting for 75% of the total pay in 2021.
Drachman also received $208.4K in non-equity incentive plan, $438.6K in salary and $4.3K in other compensation.
Rankings
In 2021, Jonathan Drachman's compensation ranked 4,921st out of 12,415 executives tracked by ExecPay. In other words, Drachman earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,921 out of 12,415 | 60th |
Division Manufacturing | 2,057 out of 5,505 | 63rd |
Major group Chemicals And Allied Products | 872 out of 2,375 | 63rd |
Industry group Drugs | 781 out of 2,096 | 63rd |
Industry Pharmaceutical Preparations | 556 out of 1,546 | 64th |
Source: SEC filing on March 31, 2022.
Drachman's colleagues
We found two more compensation records of executives who worked with Jonathan Drachman at Aquinox Pharmaceuticals in 2021.